publicFounded 2013
Recursion Pharmaceuticals
Funding Summary
Total Funding
$1B+
Latest Valuation
~$2B (public market cap)
About
AI-driven drug discovery company using high-throughput cellular imaging and machine learning to map biology at scale. Their phenomics platform screens millions of biological perturbations weekly.
Products
recursion-osphenomics-platform
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →